|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
17.520 -0.880 (-4.783%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | ||
| Turnover | 21,315,899 | 0.194% | 21,274,606 | 16,877,537 | 13,965,179 | 14,085,146 | |
| Cost of Sales | (10,698,520) | -7.577% | (11,575,661) | (8,256,422) | (6,215,872) | (5,598,983) | |
| Gross Profit | 10,617,379 | 9.469% | 9,698,945 | 8,621,115 | 7,749,307 | 8,486,163 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (57,976) | 153.613% | (22,860) | (14,804) | (42,765) | (21,918) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,022,263 | 27.940% | 799,019 | 831,809 | 652,406 | 734,122 | |
| Profit / (Loss) before Taxation | 2,661,640 | 11.900% | 2,378,581 | 3,304,229 | 2,301,688 | 2,196,150 | |
| Taxation | (610,245) | 19.871% | (509,086) | (550,647) | (392,081) | (376,521) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (267,753) | -15.266% | (315,991) | (271,209) | (194,897) | (303,509) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,783,642 | 14.814% | 1,553,504 | 2,482,373 | 1,714,710 | 1,516,120 | |
| Net Finance Costs / (Income) | 431,881 | 35.059% | 319,771 | 304,120 | 331,442 | 460,290 | |
| Depreciation & Amortisation | 1,565,006 | 47.042% | 1,064,326 | 945,447 | 836,268 | 740,252 | |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A | |
Market Valuation Indicators
| EPS (cts) | 67.000 | -- | 60.000 | 97.000 | 67.000 | 59.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 16.996 | -- | 14.885 | 14.751 | 12.869 | 11.187 |
| Remarks: | Real time quote last updated: 03/10/2023 17:34 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,783,642 |
| %Change | 14.814% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 16.996 |